Home › Type 1 Diabetes › NCT06171412
Glu-COACH: a Peer-mentoring Intervention to Reduce Disparities in Continuous Glucose Monitor (CGM) Use
Who can join
Ages 13 to 21 · All sexes
Full eligibility criteria
Inclusion Criteria: * Diagnosis of type 1 diabetes, as determined clinically by the presence of ketosis or ketoacidosis at presentation and/or the presence of at least one diabetes-related auto-antibody * Self-identification as Black and/or Latinx. * Ability of participant to comprehend and communicate in written and spoken English, in order to complete surveys and participate in mentioning sessions and other interview (parents/caregivers do not need to have English fluency) * Access to personal cellphone or tablet to participate in remote video sessions with the peer mentor * using CGM \<50% of the time over the last 3 months Exclusion Criteria: * Participants with a prior severe skin reaction to CGM sensor or adhesive. * Current use of CGM * Current or planned pregnancy * Inability to comprehend or communicate in spoken/written English * Subjects with other medical or mental health conditions that would, in the opinion of the investigators, interfere with the conduct of the study or present additional risk to the individual.
About the study
This is a study to develop and evaluate a peer mentoring intervention for Black and Latinx adolescents with type 1 diabetes to increase the initiation and maintenance of a continuous glucose monitoring (CGM) device. This device is a standard of care to improve diabetes management related to diet, exercise, and insulin. Use of CGM has been shown to improve health outcomes, but is not used by adolescents of color. Peer mentors may help improve usage.
What is being tested
- Glu-COACH (behavioral)
Sponsor: Yale University · Participants: 38 · Started: May 21, 2024
Contact the study team
- Stuart A Weinzimer, MD · Phone: 877.925.3637
- Robin Whittemore, PhD, APRN, FAAN · Phone: 203-737-2351
Official record on ClinicalTrials.gov — NCT06171412
Locations in the U.S.
| Connecticut | Yale Children's Diabetes Clinic, New Haven |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.